E-ISSN 2149-388X | ISSN 2149-0430
 

Case Report 


Is Tolvaptan in the Treatment of SIADH Following Pituitary Surgery a Right Choice?

Suleyman Karakose, Ayse Zeynep Bal, Selman Unverdi, Murat Duranay.


Abstract
Background: Fluid and electrolyte disturbances, especially hyponatremia are common complications after pituitary surgeries. Syndrome of inappropriate antidiuretic hormone secretion (SIADH) is the leading cause of hyponatremia in hospitals. Fluid restriction is the first step in treatment of SIADH. In rare cases vasopressin receptor inhibitors might be useful for medical treatment.
Case Presentation: In this paper, we present a case of SIADH after a pituitary surgery with an unpredictable effect of tolvaptan.
Conclusion: Tolvaptan is the most preferred agent for the treatment of SIADH nowadays. However tolvaptan might cause unpredictable situations in the course of treatment that clinicians must be very careful and in close follow
up the patient.

Key words: Hypernatremia, hyponatremia, pituitary surgery, SIADH, tolvaptan


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Suleyman Karakose
Articles by Ayse Zeynep Bal
Articles by Selman Unverdi
Articles by Murat Duranay
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Suleyman Karakose, Ayse Zeynep Bal, Selman Unverdi, Murat Duranay. Is Tolvaptan in the Treatment of SIADH Following Pituitary Surgery a Right Choice?. Ulutas Med J. 2016; 2(3): 154-156. doi:10.5455/umj.20160703095035


Web Style

Suleyman Karakose, Ayse Zeynep Bal, Selman Unverdi, Murat Duranay. Is Tolvaptan in the Treatment of SIADH Following Pituitary Surgery a Right Choice?. https://www.ulutasmedicaljournal.com/?mno=232578 [Access: March 06, 2024]. doi:10.5455/umj.20160703095035


AMA (American Medical Association) Style

Suleyman Karakose, Ayse Zeynep Bal, Selman Unverdi, Murat Duranay. Is Tolvaptan in the Treatment of SIADH Following Pituitary Surgery a Right Choice?. Ulutas Med J. 2016; 2(3): 154-156. doi:10.5455/umj.20160703095035



Vancouver/ICMJE Style

Suleyman Karakose, Ayse Zeynep Bal, Selman Unverdi, Murat Duranay. Is Tolvaptan in the Treatment of SIADH Following Pituitary Surgery a Right Choice?. Ulutas Med J. (2016), [cited March 06, 2024]; 2(3): 154-156. doi:10.5455/umj.20160703095035



Harvard Style

Suleyman Karakose, Ayse Zeynep Bal, Selman Unverdi, Murat Duranay (2016) Is Tolvaptan in the Treatment of SIADH Following Pituitary Surgery a Right Choice?. Ulutas Med J, 2 (3), 154-156. doi:10.5455/umj.20160703095035



Turabian Style

Suleyman Karakose, Ayse Zeynep Bal, Selman Unverdi, Murat Duranay. 2016. Is Tolvaptan in the Treatment of SIADH Following Pituitary Surgery a Right Choice?. THE ULUTAS MEDICAL JOURNAL, 2 (3), 154-156. doi:10.5455/umj.20160703095035



Chicago Style

Suleyman Karakose, Ayse Zeynep Bal, Selman Unverdi, Murat Duranay. "Is Tolvaptan in the Treatment of SIADH Following Pituitary Surgery a Right Choice?." THE ULUTAS MEDICAL JOURNAL 2 (2016), 154-156. doi:10.5455/umj.20160703095035



MLA (The Modern Language Association) Style

Suleyman Karakose, Ayse Zeynep Bal, Selman Unverdi, Murat Duranay. "Is Tolvaptan in the Treatment of SIADH Following Pituitary Surgery a Right Choice?." THE ULUTAS MEDICAL JOURNAL 2.3 (2016), 154-156. Print. doi:10.5455/umj.20160703095035



APA (American Psychological Association) Style

Suleyman Karakose, Ayse Zeynep Bal, Selman Unverdi, Murat Duranay (2016) Is Tolvaptan in the Treatment of SIADH Following Pituitary Surgery a Right Choice?. THE ULUTAS MEDICAL JOURNAL, 2 (3), 154-156. doi:10.5455/umj.20160703095035